2024. NUCLEAR RECEPTOR BINDING SET DOMAIN PROTEINS: ORCHESTRATING ANTI-TUMOR IMMUNITY AND THE PROMISE OF TARGETED DEGRADATION THERAPIES. European Journal of Emerging Molecular Sciences. 1, 01 (Dec. 2024), 69–79.